Exosome-Based Topical Therapy for Facial Atopic Dermatitis
ADMSC-derived exosome products showed significant efficacy in reducing AD severity and restoring barrier function, with excellent safety profiles. Larger, randomised controlled trials with extended follow-up are recommended to confirm these findings and establish these products as viable treatment options for AD.
Authors
- Song Eun Yoon
- Kyu‐Ho Yi (ORCID: https://orcid.org/0000-0001-5572-1364)
- Jinhyun Kim (ORCID: https://orcid.org/0000-0001-5235-2612)
- Jovian Wan (ORCID: https://orcid.org/0009-0003-2507-4524)
- Jongkeun Song
- Isaac Kai Jie Wong
Institutions
- Yonsei University (KR)
- Plastic Surgery Hospital (CN)
- Dr Youth Clinic (KR)
Publication Details
- Journal
- Journal of Craniofacial Surgery
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1097/scs.0000000000011459
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.01